In a clinical trial, this small-molecule drug was found to be superior to semaglutide for lowering blood sugar.
The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial ...
Altimmune and Novo Nordisk have encountered some headwinds in recent years. Both could rebound, but one of them looks far more likely to do so. 10 stocks we like better than Novo Nordisk › The ...
Altimmune and Novo Nordisk have encountered some headwinds in recent years. Both could rebound, but one of them looks far more likely to do so. Altimmune and Novo Nordisk have both encountered ...
GLP-1 drugs have ushered in a new era in weight loss. In just a few years, medications such as semaglutide and tirzepatide, known by the brand names Ozempic, Wegovy, Mounjaro and Zepbound, have gone ...
Intermittent fasting has become one of the most talked-about weight loss trends in recent years, promising dramatic results with simple changes to when you eat. But a major Cochrane review suggests ...
Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out. By Dani Blum Scientists raced to make drugs that help people lose as much weight as ...
Weight-loss injections have rapidly moved from specialist clinics to social media feeds and high-street pharmacies. Known as GLP-1 medications, they were originally developed to support those with ...
Jordan Beaumont receives funding from the National Institute for Health and Care Research (NIHR). He is affiliated with the Association for the Study of Obesity and the Faculty of Public Health.
As an ecommerce founder or marketer, staying on top of the latest trends in the health and wellness industry is crucial for business growth. One rapidly expanding segment is weight loss supplements, ...
Sarah is an experienced writer and editor enthusiastic about helping readers live their healthiest and happiest lives. Before joining Forbes Health, Sarah worked as a writer for various digital ...